|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"tseng jeng sen"
Showing items 1-50 of 56 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-06T02:04:30Z |
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
|
Liao, Pei-Ya; Ou, Wei-Fan; Su, Kang-Yi; Sun, Ming-Hsi; Huang, Chih-Mei; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; SUNG-LIANG YU; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T02:02:15Z |
Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)
|
Wu, Jia-Jun; Lee, Po-Hsin; Zheng, Zhe-Rong; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T01:59:43Z |
Various impacts of driver mutations on the PD-L1 expression of NSCLC
|
Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Lee, Po-Hsin; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T01:55:22Z |
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients
|
Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-06-14T23:24:02Z |
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR‐Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
|
Liao, Pei Ya; Ou, Wei Fan; KANG-YI SU; Sun, Ming Hsi; Huang, Chih Mei; Chen, Kun Chieh; Hsu, Kuo Hsuan; SUNG-LIANG YU; Huang, Yen Hsiang; Tseng, Jeng Sen; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-14T23:35:34Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen Hsiang; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-14T23:35:34Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen Hsiang; Hsu, Kuo Hsuan; Chin, Chun Shih; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-12T06:47:07Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T06:43:52Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T06:04:19Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T05:59:04Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-04-14T23:27:39Z |
Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018
|
Tseng, Jeng Sen; CHUN-JU CHIANG; Chen, Kun Chieh; Zheng, Zhe Rong; Yang, Tsung Ying; Lee, Wen Chung; Hsu, Kuo Hsuan; Huang, Yen Hsiang; Liu, Tsang Wu; Hsia, Jiun Yi; Chang, Gee Chen |
| 臺大學術典藏 |
2021-11-29T06:35:37Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; YEN-TING LIN; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-29T03:24:02Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:29:42Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:28:05Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T03:48:58Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-02T07:00:50Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; CHAO-CHI HO; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-09-14T23:18:48Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M (Scientific Reports, (2021), 11, 1, (12084), 10.1038/s41598-021-91657-7)
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-30T01:35:39Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
Su, Sheng-Fang; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; SUNG-LIANG YU; Li, Ker-Chau |
| 臺大學術典藏 |
2021-07-30T01:33:54Z |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:32:10Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:04:05Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-15T05:32:06Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-15T05:31:53Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen Hsiang; Hung, Jen Yu; Ko, How Wen; Su, Po Lan; Lai, Chun Liang; Chang, Huang Chih; Hsia, Te Chun; Lin, Sheng Hao; Wu, Kuan Li; JUSTIN CHENG-TA YANG; Su, Wu Chou; Chu, Yi Chun; Wang, Chin Chou; WEI-YU LIAO; YEN-TING LIN; Lin, Ching Hsiung; Lin, Meng Chih; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; Lee, Mei Hsuan; SUNG-LIANG YU; CHAO-CHI HO; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-12T02:24:08Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
SU, SHENG-FANG; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; Yu, Sung-Liang; Li, Ker-Chau |
| 臺大學術典藏 |
2021-05-21T11:40:35Z |
Primary tumor radiotherapy during EGFR-TKI disease control improves survival of treatment Nave advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu, Kuo Hsuan; Huang, Jing Wen; Tseng, Jeng Sen; KUAN-WEN CHEN; Weng, Yih Chyang; SUNG-LIANG YU; Yang, Tsung Ying; Huang, Yen Hsiang; Chen, Jeremy J.W.; Chen, Kun Chieh; Chang, Gee Chen |
| 國立成功大學 |
2021-04-30 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee;Po-Hsin;Yang;Tsung-Ying;Chen;Kun-Chieh;Huang;Yen-Hsiang;Tseng, Jeng-Sen;Hsu;Kuo-Hsuan;Wu;Yu-Chen;Liu;Ko-Jiunn;Chang;Gee-Chen |
| 臺大學術典藏 |
2021-03-15T08:41:47Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Su, Kang-Yi;Sung-Liang Yu;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:38:25Z |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
|
Chang, Gee-Chen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Huang, Yen-Hsiang;Kang-Yi Su;Yu, Sung-Liang;Tseng, Jeng-Sen; Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Tseng, Jeng-Sen |
| 臺大學術典藏 |
2021-03-11T05:35:04Z |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU; Yu, Sung-Liang; Chang, Gee-Chen |
| 國立交通大學 |
2020-07-01T05:22:11Z |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
|
Raghav, Lovely; Chang, Ya-Hsuan; Hsu, Yi-Chiung; Li, Yu-Cheng; Chen, Chih-Yi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chuang, Cheng-Yen; Lee, Mei-Hsuan; Wang, Chih-Liang; Chen, Huei-Wen; Yu, Sung-Liang; Su, Sheng-Fang; Yuan, Shin-Sheng; Chen, Jeremy J. W.; Ho, Shinn-Ying; Li, Ker-Chau; Yang, Pan-Chyr; Chang, Gee-Chen; Chen, Hsuan-Yu |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
|
Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2020-02-10T09:00:24Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemona?ve patients with EGFR-mutant lung adenocarcinoma
|
MONG-HSUN TSAI; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Jeremy Jw; Su, Kang-Yi; Yu, Sung-Liang; Tsai, Meen-Hsin; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren |
| 臺大學術典藏 |
2020-02-10T09:00:23Z |
Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2020-02-10T09:00:22Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng, Chien-Hua; Chiang, Chun-Ju; Tseng, Jeng-Sen; Yang, Tsung-Ying; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Wang, Chih-Liang; Chen, Chih-Yi; Yen, Sang-Hue; Tsai, Chun-Ming; Huang, Ming-Shyan; Ho, Chao-Chi; Yu, Chong-Jen; Tsai, Ying-Huang; Chen, Jin-Shing; Chou, Teh-Ying; Tsai, Ming-Hsun; Chen, Hsuan-Yu; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Huei-Wen; Yu, Sung-Liang; Liu, Tsang-Wu; Chang, Gee-Chen; MONG-HSUN TSAI |
| 臺大學術典藏 |
2019-11-08T03:15:57Z |
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Hsu, Chia-Hung; KANG-YI SU; Chen, Jeremy J W; HUEI-WEN CHEN; SUNG-LIANG YU; Yang, Tsung-Ying; Chang, Gee-Chen; Huang, Yen-Hsiang;Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Chen, Kun-Chieh;Hsu, Chia-Hung;Kang-Yi Su;Chen, Jeremy J W;Huei-Wen Chen;Sung-Liang Yu;Yang, Tsung-Ying;Chang, Gee-Chen |
| 臺大學術典藏 |
2019-01-18 |
The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan
|
Liu, Tsang-Wu;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Yang, Tsung-Ying;Tseng, Jeng-Sen;Tseng, Chien-Hua;Chang, Gee Chen;CHANG-CHUAN CHAN;WEN-CHUNG LEE;SUNG-LIANG YU;Ku, Kai Chen;CHUN-JU CHIANG;Tsuang, Ben Jei; Chang, Gee Chen; CHANG-CHUAN CHAN; Liu, Tsang-Wu; Tseng, Chien-Hua; Tsuang, Ben Jei; CHIANG,CHUN-JU; Ku, Kai Chen; Tseng, Jeng-Sen; Yang, Tsung-Ying; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; SUNG-LIANG YU; WEN-CHUNG LEE |
| 臺大學術典藏 |
2018-09-10T15:34:42Z |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu, Chia-Hung;Tseng, Chien-Hua;Chiang, Chun-Ju;Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Chen, Kun-Chieh;Wang, Chih-Liang;Chen, Chih-Yi;Yen, Sang-Hue;Chiu, Chao-Hua;Huang, Ming-Shyan;Yu, Chong-Jen;Tsai, Ying-Huang;Chen, Jin-Shing;Tsai, Chun-Ming;Chou, Teh-Ying;Lin, Kuei-Chih;Tsai, Ming-Hsun;Lee, Wen-Chung;Ku, Hsiu-Ying;Liu, Tsang-Wu;Yang, Tsung-Ying;Chang, Gee-Chen; Hsu, C.-H. and Tseng, C.-H. and Chiang, C.-J. and Hsu, K.-H. and Tseng, J.-S. and Chen, K.-C. and Wang, C.-L. and Chen, C.-Y. and Yen, S.-H. and Chiu, C.-H. and Huang, M.-S. and Yu, C.-J. and Tsai, Y.-H. and Chen, J.-S. and Tsai, C.-M. and Chou, T.-Y. and Lin, K.-C. and Tsai, M.-H. and Lee, W.-C. and Ku, H.-Y. and Liu, T.-W. and Yang, T.-Y. and Chang, G.-C.; 余忠仁;李文宗;陳晉興; 余忠仁;李文宗;陳晉興; Hsu, Chia-Hung; Hsu, Chia-Hung; Chong-Jen Yu; Tseng, Chien-Hua; WEN-CHUNG LEE; JIN-SHING CHEN; Chiang, Chun-Ju; CHIANG,CHUN-JU; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Wang, Chih-Liang; Chen, Chih-Yi; Chen, Chih-Yi; Yen, Sang-Hue; Yen, Sang-Hue; Chiu, Chao-Hua; Chiu, Chao-Hua; Huang, Ming-Shyan; Yu, Chong-Jen; Yu, Chong-Jen; Tsai, Ying-Huang; Chen, Jin-Shing; Chen, Jin-Shing; Tsai, Chun-Ming; Tsai, Chun-Ming; Chou, Teh-Ying; Chou, Teh-Ying; Lin, Kuei-Chih; Lin, Kuei-Chih; Tsai, Ming-Hsun; Tsai, Ming-Hsun; Lee, Wen-Chung; Lee, Wen-Chung; Ku, Hsiu-Ying; Liu, Tsang-Wu; Liu, Tsang-Wu; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2018-09-10T15:33:32Z |
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
|
Liu, Chien-Ming; Yang, Pan-Chyr; Chen, Jeremy J. W.; Chang, Gee-Chen; ?????; Wu, Ming-Fang; Chiu, Kuo-Liang; Hsia, Te-Chun; Ho, Chao-Chi; Yu, Chong-Jen; Su, Kang-Yi; Yang, Cheng-Ta; Yu, Sung-Liang; Tsai, Chi-Ren; Chen, Hsuan-Yu; Chen, Kun-Chieh; Hsu, K.-H. and Tseng, J.-S. and Wang, C.-L. and Yang, T.-Y. and Tseng, C.-H. and Chen, H.-Y. and Chen, K.-C. and Tsai, C.-R. and Yang, C.-T. and Yu, S.-L. and Su, K.-Y. and Yu, C.-J. and Ho, C.C. and Hsia, T.-C. and Wu, M.-F. and Chiu, K.-L. and Liu, C.-M. and Yang, P.-C. and Chen, J.J.W. and Chang, G.-C.; Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Wang, Chih-Liang;Yang, Tsung-Ying;Tseng, Chien-Hua;Chen, Hsuan-Yu;Chen, Kun-Chieh;Tsai, Chi-Ren;Yang, Cheng-Ta;Yu, Sung-Liang;Su, Kang-Yi;Yu, Chong-Jen;Ho, Chao-Chi;Hsia, Te-Chun;Wu, Ming-Fang;Chiu, Kuo-Liang;Liu, Chien-Ming;Yang, Pan-Chyr;Chen, Jeremy J. W.;Chang, Gee-Chen; Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Wang, Chih-Liang;Yang, Tsung-Ying;Tseng, Chien-Hua;Chen, Hsuan-Yu;Chen, Kun-Chieh;Tsai, Chi-Ren;Yang, Cheng-Ta;Yu, Sung-Liang;Su, Kang-Yi;Yu, Chong-Jen;Ho, Chao-Chi;Hsia, Te-Chun;Wu, Ming-Fang;Chiu, Kuo-Liang;Liu, Chien-Ming;Yang, Pan-Chyr;Chen, Jeremy J. W.;Chang, Gee-Chen; 俞松良;蘇剛毅;楊泮池;余忠仁;何肇基; 俞松良;蘇剛毅;楊泮池;余忠仁;何肇基; SUNG-LIANG YU; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; CHONG-JEN YU; Wang, Chih-Liang; KANG-YI SU; CHAO-CHI HO; Yang, Tsung-Ying; Tseng, Chien-Hua |
| 臺大學術典藏 |
2018-09-10T15:27:22Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan
|
Hsu, Kuo-Hsuan;Ho, Chao-Chi;Hsia, Te-Chun;Tseng, Jeng-Sen;Su, Kang-Yi;Wu, Ming-Fang;Chiu, Kuo-Liang;Yang, Tsung-Ying;Chen, Kun-Chieh;Ooi, Hean;Wu, Tzu-Chin;Chen, Hung-Jen;Chen, Hsuan-Yu;Chang, Chi-Sheng;Hsu, Chung-Ping;Hsia, Jiun-Yi;Chuang, Cheng-Yen;Lin, Chin-Hung;Chen, Jeremy J. W.;Chen, Kuan-Yu;Liao, Wei-Yu;Shih, Jin-Yuan;Yu, Sung-Liang;Yu, Chong-Jen;Yang, Pan-Chyr;Chang, Gee-Chen; Hsu, K.-H. and Ho, C.-C. and Hsia, T.-C. and Tseng, J.-S. and Su, K.-Y. and Wu, M.-F. and Chiu, K.-L. and Yang, T.-Y. and Chen, K.-C. and Ooi, H. and Wu, T.-C. and Chen, H.-J. and Chen, H.-Y. and Chang, C.-S. and Hsu, C.-P. and Hsia, J.-Y. and Chuang, C.-Y. and Lin, C.-H. and Chen, J.J.W. and Chen, K.-Y. and Liao, W.-Y. and Shih, J.-Y. and Yu, S.-L. and Yu, C.-J. and Yang, P.-C. and Chang, G.-C.; 俞松良;蘇剛毅;楊泮池;廖唯昱;陳冠宇;余忠仁;何肇基;施金元; Hsu, Kuo-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chong-Jen Yu; Hsia, Te-Chun; WEI-YU LIAO; Tseng, Jeng-Sen; KANG-YI SU; JIN-YUAN SHIH; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen |
| 臺大學術典藏 |
2018-09-10T15:24:44Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Ho, Chao-Chi; Hsia, Te-Chun; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Tsung-Ying; Chang, Gee-Chen; Tseng, Chien-Hua; 楊泮池; SUNG-LIANG YU; WEI-YU LIAO; CHONG-JEN YU; KANG-YI SU; CHAO-CHI HO; JIN-YUAN SHIH; Yang, Pan-Chyret al. |
| 臺大學術典藏 |
2018-09-10T14:49:40Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Yu, Chong-Jen;Liao, Wei-Yu;Tsai, Chi-Ren;Tsai, Meen-Hsin;Yu, Sung-Liang;Su, Kang-Yi;Chen, Jeremy J. W.;Chen, Hsuan-Yu;Chang, Gee-Chen; Tseng, J.-S. and Yang, T.-Y. and Chen, K.-C. and Hsu, K.-H. and Yu, C.-J. and Liao, W.-Y. and Tsai, C.-R. and Tsai, M.-H. and Yu, S.-L. and Su, K.-Y. and Chen, J.J.W. and Chen, H.-Y. and Chang, G.-C.; 俞松良;蘇剛毅;廖唯昱;余忠仁; SUNG-LIANG YU; Tseng, Jeng-Sen; Tseng, Jeng-Sen; CHONG-JEN YU; Yang, Tsung-Ying; Yang, Tsung-Ying; Chen, Kun-Chieh; WEI-YU LIAO; Hsu, Kuo-Hsuan; KANG-YI SU; Yu, Chong-Jen; Yu, Chong-Jen; Liao, Wei-Yu; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Yu, Sung-Liang; Su, Kang-Yi; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chen, Hsuan-Yu; Chang, Gee-Chen |
| 臺大學術典藏 |
2018-09-10T05:02:03Z |
Growth hormone cannot enhance the recovery of dexamethasone-induced osteopenia after withdrawal in young female wistar rats
|
Tseng, Jeng-Sen; TIEN-SHANG HUANG; Yang, Rong-Sen; Wang, Chih-Liang; Tsai, Tsang-Wu; Liu, Shin-Hwa; Yang, Tsung-Ying; Tseng, Chien-Hua; Chen, Hsuan-Yu; Chen, Kun-Chieh; Tsai, Chi-Ren; Yang, Cheng-Ta; Yu, Sung-Liang; Su, Kang-Yi; Yu, Chong-Jen; Ho, Chao-Chi; Hsia, Te-Chun; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Yang, Pan-Chyr; Chen, Jeremy J. W.; Chang, Gee-Chen; RONG-SEN YANG; Huang, T.-S.;Yang, R.-S.;Tsai, T.-W.;Liu, L.-H.Huang, Tien-Shang; Yang, Rong-Sen; Tsai, Tsang-Wu; Liu, Shin-Hwa; 俞松良; 蘇剛毅; 楊泮池; 余忠仁; 何肇基; Huang, Tien-Shang; Hsu, Kuo-Hsuan |
| 國立臺灣大學 |
2016 |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng, Chien-Hua; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Ho, Chao-Chi; Hsia, Te-Chun; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Tsung-Ying; Chang, Gee-Chen; 俞松良; 蘇剛毅; 楊泮池; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 施金元 |
| 國立臺灣大學 |
2016 |
Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Su, Kang-Yi; Chen, Hsuan-Yu; Chang, Chi-Sheng; Chen, Jeremy J. W.; Yu, Sung-Liang; Chen, Huei-Wen; Yang, Tsung-Ying; Chang, Gee-Chen; 俞松良; 蘇剛毅; 陳惠文 |
| 國立臺灣大學 |
2016 |
The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
|
Tseng, Jeng-Sen; Su, Kang-Yi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Chen, Hsuan-Yu; Tsai, Chi-Ren; Yu, Sung-Liang; Chang, Gee-Chen; 俞松良; 蘇剛毅 |
| 國立臺灣大學 |
2016 |
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
|
Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Wang, Chih-Liang; Yang, Tsung-Ying; Tseng, Chien-Hua; Chen, Hsuan-Yu; Chen, Kun-Chieh; Tsai, Chi-Ren; Yang, Cheng-Ta; Yu, Sung-Liang; Su, Kang-Yi; Yu, Chong-Jen; Ho, Chao-Chi; Hsia, Te-Chun; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Yang, Pan-Chyr; Chen, Jeremy J. W.; Chang, Gee-Chen; 俞松良; 蘇剛毅; 楊泮池; 余忠仁; 何肇基 |
| 國立臺灣大學 |
2016 |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu, Chia-Hung; Tseng, Chien-Hua; Chiang, Chun-Ju; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Wang, Chih-Liang; Chen, Chih-Yi; Yen, Sang-Hue; Chiu, Chao-Hua; Huang, Ming-Shyan; Yu, Chong-Jen; Tsai, Ying-Huang; Chen, Jin-Shing; Tsai, Chun-Ming; Chou, Teh-Ying; Lin, Kuei-Chih; Tsai, Ming-Hsun; Lee, Wen-Chung; Ku, Hsiu-Ying; Liu, Tsang-Wu; Yang, Tsung-Ying; Chang, Gee-Chen; 余忠仁; 李文宗; 陳晉興 |
| 國立成功大學 |
2015-07-10 |
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability
|
Chen, Hsuan-Yu;Yu, Sung-Liang;Ho, Bing-Ching;Su, Kang-Yi;Hsu, Yi-Chiung;Chang, Chi-Sheng;Li, Yu-Cheng;Yang, Shi-Yi;Hsu, Pin-Yen;Ho, Hao;Chang, Ya-Hsuan;Chen, Chih-Yi;Yang, Hwai-I;Hsu, Chung-Ping;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Hsia, Jiun-Yi;Chuang, Cheng-Yen;Yuan, Shinsheng;Lee, Mei-Hsuan;Liu, Chia-Hsin;Wu, Guan-I;Hsiung, Chao A.;Chen, Yuh-Min;Wang, Chih-Liang;Huang, Ming-Shyan;Yu, Chong-Jen;Chen, Kuan-Yu;Tsai, Ying-Huang;Su, Wu-Chou;Chen, Huei-Wen;Chen, Jeremy J. W.;Chen, Chien-Jen;Chang, Gee-Chen;Yang, Pan-Chyr;Li, Ker-Chau |
Showing items 1-50 of 56 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
